Related Experiment Videos
Achilles tendinitis associated with fluoroquinolones
P D van der Linden1, J van de Lei, H W Nab
1Pharmaco-epidemiology Unit, Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.
British Journal of Clinical Pharmacology
|October 6, 1999
Summary
This study suggests fluoroquinolone antibiotics may increase the risk of Achilles tendinitis. Ofloxacin showed the highest risk increase, indicating a potential link between these drugs and tendon issues.
Area of Science:
- Pharmacovigilance
- Musculoskeletal Health
- Infectious Disease Management
Background:
- Fluoroquinolones are broad-spectrum antibiotics with known side effects.
- Tendinitis and tendon rupture are potential adverse events associated with antibiotic use.
- Understanding drug-related risks is crucial for patient safety and appropriate prescribing.
Purpose of the Study:
- To investigate the association between fluoroquinolone use and tendinitis.
- To assess the risk of tendinitis in a large, real-world population.
- To identify specific fluoroquinolones that may pose a higher risk.
Main Methods:
- Retrospective cohort study utilizing a large general practice database (IPCI).
- Inclusion of patients treated with fluoroquinolones or other common antibiotics (amoxicillin, trimethoprim, cotrimoxazole, nitrofurantoin).
- Careful case definition and exclusion criteria for tendinitis/tendon rupture, with adjustments for confounders like age, gender, and corticosteroid use.
Main Results:
- A higher risk of tendinitis was observed with fluoroquinolone use compared to other antibiotics.
- The adjusted relative risk for Achilles tendinitis was 3.7, and for other tendinitis types was 1.3.
- Ofloxacin demonstrated a significantly elevated risk for Achilles tendinitis (RR 10.1), with an excess risk of 15 cases per 100,000 exposure days.
Conclusions:
- The study suggests a potential increased risk of Achilles tendinitis associated with certain fluoroquinolones.
- Ofloxacin appears to carry the highest risk among the fluoroquinolones studied.
- Further research with larger sample sizes is warranted to confirm these findings.